ENTITY
Jinxin Fertility

Jinxin Fertility (1951 HK)

126
Analysis
Health Care • China
Jinxin Fertility Group is a leading international provider of assisted reproductive services (ARS) and assisted reproductive technology (ART). Its core offerings include In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), egg retrieval, embryo transfer, and genetic screening, alongside a range of women's health services. The company is headquartered in Chengdu, China, and was founded in 1951.
more
bullish•Alibaba
•22 Jun 2019 12:52

ECM Weekly (22 Jun 2019) -  Alibaba, Budweiser Brewing Co, Ascentage, CIMC Vehicle, Impro Precision

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
•19 Jun 2019 06:09

Last Week in GER Research: Wanda Sports, Budweiser APAC, Jinxin Fertility, Vocus and ESR-REIT

Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team. This week we initiate coverage on the Wanda...

Logo
652 Views
Share
bullish•Alibaba
•15 Jun 2019 12:14

ECM Weekly (15 Jun 2019) - Budweiser Brewing Co, Jinxin Fertility, Wanda Sports, Hansoh Pharma

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
•14 Jun 2019 15:15

Jinxin Fertility Group IPO: Valuation Reasonable for the Trade-Offs

Jinxin Fertility Co Ltd (1951 HK) is a leading assisted reproductive service (ARS) provider in China and the US. It announced its IPO price...

Logo
1.2k Views
Share
•12 Jun 2019 00:42

Jinxin Fertility Group IPO: 4Q Update Is Good but Is It Sustainable?

Jinxin Fertility Co Ltd (1951 HK) is a leading assisted reproductive service (ARS) provider in China and the US. Its network of ARS medical...

Logo
990 Views
Share
x